GlassScriptPhysician profile
Brett D Whatcott
NPI 1134169816
$9,506.91
in general payments reported to CMS, 2019-2025
18 companies · $59.38 in 2025
The $59.38 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.52 · 2020: $76.86 · 2021: $4,313 · 2022: $1,208 · 2023: $3,443 · 2024: $325 · 2025: $59.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,258 · Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,258.17 |
| Food and Beverage | $1,568.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,176.69 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $1,887.87 | 2022-2024 | Proclaim, Eterna, Octrode |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $480.68 | 2022-2025 | Relistor |
| Tersera Therapeutics LLC | $199.35 | 2022-2024 | Prialt |
| Collegium Pharmaceutical, INC. | $160.91 | 2021-2023 | Belbuca, Xtampza |
| Eisai INC. | $143.98 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $130.46 | 2019-2021 | |
| Horizon Therapeutics Plc | $54.48 | 2022 | |
| Boston Scientific Corporation | $52.83 | 2022 | |
| Alnylam Pharmaceuticals INC. | $49.77 | 2023 | |
| Pfizer INC. | $33.49 | 2020-2023 | |
| Medtronic USA, INC. | $33.11 | 2020 | |
| Grt US Holding, INC. | $32.28 | 2022 | |
| Averitas Pharma INC. | $19.14 | 2025 | Qutenza |
| Saluda Medical Americas, INC. | $17.40 | 2024 | Evoke |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $15.78 | 2024 | Mild Device Kit |
| Abbvie INC. | $14.20 | 2022 | |
| Kinex Medical Company LLC | $4.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Whatcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.